Oficiálny časopis Slovenskej kardiologickej spoločnosti,
Slovenskej hypertenziologickej spoločnosti a Slovenskej asociácie srdcových arytmií

Cardiology Letters 2023, 32(3):213-215

Paravalvular leak treatment with a transapical valve-in-valve implantation of a Sapien 3 ultra valve after transfemoral transcatheter aortic valve implantation of a Portico transcatheter valve

Gasparovic I1, Bena M1, Artemiou P1, Hudec V1, Drangova E2, Hulman M1
1 Faculty of Medicine, Comenius University in Bratislava, National Institute of Cardiovascular Diseases, Clinic of Cardiac Surgery, Bratislava, Slovakia
2 Faculty of Medicine, Slovak Medical University, National Institute of Cardiovascular Diseases, Bratislava, Slovakia

Uverejnené: March 1, 2023  Zobraziť citáciu

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gasparovic I, Bena M, Artemiou P, Hudec V, Drangova E, Hulman M. Paravalvular leak treatment with a transapical valve-in-valve implantation of a Sapien 3 ultra valve after transfemoral transcatheter aortic valve implantation of a Portico transcatheter valve. Cardiology Letters. 2023;32(3):213-215.
Stiahnuť citáciu

Referencie

  1. Conzelman L, Grotherr P, Dapening L, et al. Valve-related complications in TAVI leading to emergent cardiac surgery. Thorac Cardiovasc Surg 2022, doi:10.1055/s-0042-1758073 Prejsť k pôvodnému zdroju...
  2. Fontana GP, Bedogni F, Groh M, et al. One-year result of the Portico transcatheter aortic heart valve using the next-generation FlexNav delivery system. J Soc Cardiovasc Angiogr Interv 2022, doi:10.1016/j.jscai.2022.100562 Prejsť k pôvodnému zdroju...
  3. Linke A, Holzhey D, Mollmann H, et al. Treatment of aortic stenosis with a self-expanding, resheathable transcatheter valve. One-year results of the international multicenter Portico transcatheter aortic valve implantation system study. Circ Cardiovasc Interv 2018:11:e005206.doi:10.101161/CIRCINTERVENTIONS.117.005206 Prejsť k pôvodnému zdroju...
  4. Barbandi M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv 2016:9:e003930.doi: 10.1161/CIRCINTERVENTIONS.116.003930 Prejsť k pôvodnému zdroju...